Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 29
- Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)From1 Oct 2018 → 28 Feb 2023Funding: FWO fellowships
- Clin-IC: Medtech solutions for patientsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal
- Investigating modifiers of C9orf72 induced pathology in Amyotrophic Lateral Sclerosis (ALS) using zebrafish.From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
- The role of EphA4 in neural repair following ischemic strokeFrom1 Apr 2014 → 16 Mar 2020Funding: BOF - Doctoral projects, FWO fellowships
- JP ND-ALS-CarE : A programme for ALS Care in Europe.From1 Feb 2014 → 31 Jan 2019Funding: FWO research project (including WEAVE projects)
- Identifying COL4A1 and COL4A2 mutations in sporadic cerebral white matter diseaseFrom1 Jan 2014 → 31 Dec 2014Funding: FWO research grant KAN
- The ephrin axon repellent system in amyotrophic lateral sclerosis (ALS).From1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- The mechanism of mutant C9orf72 in the pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Lobe Degeneration.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The ephrin axonal repellent system in Amyotrophic Lateral Sclerosis.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
Publications
181 - 190 of 198
- Differential contribution of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1 to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons(2009)
Authors: Karel Talavera Pérez, Leen Verbert, Jan Eggermont, Humbert De Smedt, Ludo Van Den Bosch, Wim Robberecht, Geert Callewaert
Pages: 1168 - 1176 - TDP-43 M311V mutation in familial amyotrophic lateral sclerosis(2009)
Authors: Robin Lemmens, Gert Matthijs, Ludo Van Den Bosch, Philip Van Damme, Bénédicte Dubois, Steven Boonen, An Goris, Wim Robberecht
Pages: 354 - 355 - Peripheral neuropathy and 46XY gonadal dysgenesis: a heterogeneous entity(2009)
Authors: Wim Robberecht
Pages: 172 - 175 - Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration(2009)
Authors: Ludo Van Den Bosch, Annelies Van Hoecke, Peter Carmeliet, Patrik Verstreken, Wim Robberecht
Pages: 472 - 481 - Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis(2009)
Authors: Diether Lambrechts, Wim Robberecht
Pages: 441 - 7 - Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study(2009)
Authors: Greet Hermans, Maarten Schrooten, Philip Van Damme, Wim Robberecht, Greet Van den Berghe
- Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke(2009)
Authors: Wim Robberecht, Luc Vanhees, Vincent Thijs, An Goris
Pages: 1287 - 1293 - Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration(2008)
Authors: Koen Poesen, Diether Lambrechts, Philip Van Damme, Elke Bogaert, Bart Claes, Line Heylen, An Verheyen, Marc Tjwa, Ludo Van Den Bosch, Theo Meert, et al.
Pages: 10451 - 10459 - Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase(2008)
Authors: Thomas Philips, Bart Van Wijmeersch, Ludo Van Den Bosch, An Billiau, Wim Robberecht
Pages: 10234 - 10244 - Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis(2008)
Authors: Jyothsna Krishnan, Maria Andries, Etienne Waelkens, Wim Robberecht, Ludo Van Den Bosch
Pages: 2170 - 2183
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)